This compound is primarily utilized in the field of antiviral research and drug development. It serves as a nucleoside analog, which means it mimics the structure of natural nucleosides, allowing it to interfere with viral replication processes. Specifically, it has shown potential in targeting RNA viruses by incorporating itself into viral RNA during replication, leading to errors in the genetic code and ultimately inhibiting the virus's ability to reproduce. Researchers are exploring its efficacy against a range of viral infections, including those caused by flaviviruses and coronaviruses. Additionally, its difluoromethyl group enhances its stability and bioavailability, making it a promising candidate for further pharmaceutical studies.